SCHEMBL6155053

SCHEMBL6155053

CC1CC(c2ccccc2)=NO1

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
ATM Q13315 1/20 0.42
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11982686 0.83 POLB (0.39) CA1CA2
SCHEMBL8578279 0.82 MAOB (0.51)
SCHEMBL15275699 0.81 CA1 (0.41) CA1CA2ATM
SCHEMBL6156849 0.81 POLB (0.57) ATM
SCHEMBL20244567 0.81 ALDH1A1 (0.41) CA1CA2
SCHEMBL14952332 0.81 CA1 (0.53) CA1CA2
SCHEMBL13662846 0.80 KDM4E (0.49) PKM
SCHEMBL19522413 0.79 CA1 (0.57) CA1CA2
SCHEMBL28653891 0.78 CA1 (0.49) CA1CA2ATMPKM
SCHEMBL19873011 0.78 MIF (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933283-B2 11-deoxy azalide antibacterials ABBOTT LABORATORIES (US) 2005-08-23 US claimed
EP-1501847-A2 11-DEOXY AZALIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-02-02 EP claimed
EP-1499326-A1 OXOLIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-01-26 EP claimed
US-20040014953-A1 11-Deoxy azalide antibacterials ABBVIE INC. 2004-01-22 US claimed
WO-2003090679-A2 11-DEOXY AZALIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO claimed
WO-2003090760-A1 OXOLIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO claimed
US-20230130980-A1 HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS TECHFIELDS PHARMA CO., LTD. (CN) 2023-04-27 US disclosed
US-11485744-B2 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds TECHFIELDS PHARMA CO., LTD. (CN) 2022-11-01 US disclosed
WO-2019012063-A1 BICYCLIC KETONE COMPOUNDS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2019-01-17 WO disclosed
US-9750252-B2 Arylalkyloxy pyrimidine derivative, pesticide for agricultural and horticultural use containing arylalkyloxy pyrimidine derivative as active ingredient, and use of same NIHON NOHYAKU., LTD. (JP) 2017-09-05 US disclosed
US-9750252-B2 Arylalkyloxy pyrimidine derivative, pesticide for agricultural and horticultural use containing arylalkyloxy pyrimidine derivative as active ingredient, and use of same NIHON NOHYAKU., LTD. (JP) 2017-09-05 US disclosed
US-20150005257-A1 ARYLALKYLOXY PYRIMIDINE DERIVATIVE, PESTICIDE FOR AGRICULTURAL AND HORTICULTURAL USE CONTAINING ARYLALKYLOXY PYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT, AND USE OF SAME NIHON NOHYAKU CO. OLTD. (JP) 2015-01-01 US disclosed
US-20150005257-A1 ARYLALKYLOXY PYRIMIDINE DERIVATIVE, PESTICIDE FOR AGRICULTURAL AND HORTICULTURAL USE CONTAINING ARYLALKYLOXY PYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT, AND USE OF SAME NIHON NOHYAKU CO. OLTD. (JP) 2015-01-01 US disclosed
US-6933283-B2 11-deoxy azalide antibacterials ABBOTT LABORATORIES (US) 2005-08-23 US disclosed
EP-1501847-A2 11-DEOXY AZALIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-02-02 EP disclosed
EP-1499326-A1 OXOLIDE ANTIBACTERIALS Abbott Laboratories (US) 2005-01-26 EP disclosed
US-20040014953-A1 11-Deoxy azalide antibacterials ABBVIE INC. 2004-01-22 US disclosed
WO-2003090679-A2 11-DEOXY AZALIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO disclosed
WO-2003090760-A1 OXOLIDE ANTIBACTERIALS ABBOTT LABORATORIES (US) 2003-11-06 WO disclosed
CN-1143363-A Isoxazoline compounds as inhibitors of TNF release PFIZER (US) 1997-02-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485744-B2 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds SLC7A1, VIP, HPGDS CA1 4406/4885CA2 3898/4885ATM 3960/4885
US-20230130980-A1 HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS SLC7A1, VIP, HPGDS CA1 4406/4885CA2 3898/4885ATM 3960/4885
US-20150005257-A1 ARYLALKYLOXY PYRIMIDINE DERIVATIVE, PESTICIDE FOR AGRICULTURAL AND HORTICULTURAL USE CONTAINING ARYLALKYLOXY PYRIMIDINE DERIVATIVE AS ACTIVE INGREDIENT, AND USE OF SAME DDT, HDHD5, DPYSL2 CA1 3734/4885CA2 1608/4885ATM 1576/4885
US-20040014953-A1 11-Deoxy azalide antibacterials TOP1, TOP2B, TOP2A CA1 3536/4885CA2 4255/4885ATM 4431/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.